体外膜肺氧合技术在持续肺动脉高压新生儿救治中的临床应用

doi:10.7499/j.issn.1008-8830.2202053

摘要
图/表
参考文献(22)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (845 KB) [HTML]
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的探讨体外膜肺氧合技术（extracorporeal membrane oxygenation，ECMO）在新生儿持续肺动脉高压（persistent pulmonary hypertension of the newborn，PPHN）救治中的临床应用价值。方法回顾性收集2015年1月至2021年12月在中山市人民医院新生儿重症监护室中应用ECMO支持的11例PPHN新生儿的临床资料，包括患儿的一般资料、临床诊断、实验室检查、ECMO支持时间及过程中各种并发症、住院时间、结局等，进行比较分析。结果 11例患儿中有10例撤机成功，撤机成功率91%；存活8例，存活率73%。11例患儿ECMO治疗时间26~185 h，平均治疗时间（81±50）h；呼吸机治疗时间57~392 h，平均治疗时间（198±105）h；住院时间2~49 d，平均住院时间（22±15）d。11例患儿ECMO治疗24 h后氧合指数、血乳酸水平较ECMO治疗前均显著改善（P<0.05）；其中10例患儿ECMO治疗24 h后肺动脉压力较ECMO治疗前均显著下降（P<0.05）；1例患儿在EMCO治疗期间肺动脉压力呈进行性升高，最终死亡，结合尸检肺组织病理及全外显子测序结果，确诊为肺泡毛细血管发育不良。11例患儿ECMO治疗期间发生颅内出血5例，弥散性血管内凝血1例，胃出血1例，肺出血2例，肾功能不全1例，穿刺处出血3例。结论 ECMO技术是一种有效应用于常规治疗无效的PPHN新生儿救治的心肺支持措施。应用ECMO技术的并发症发生率高，需严格掌握适应证、把握时机、提高ECMO管理水平，才能提高患儿的撤机率及存活率。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈玉兰
	杨秀芳
	陈简
	施尚文
	朱侨伟
	廖小卒
	张明光

关键词 ：持续肺动脉高压, 体外膜肺氧合技术, 肺泡毛细血管发育不良, 新生儿

Abstract：Objective To study the clinical value of extracorporeal membrane oxygenation (ECMO) in the treatment of persistent pulmonary hypertension of the newborn (PPHN). Methods A retrospective analysis was performed on the medical data of 11 neonates with PPHN who were treated with ECMO in the Neonatal Intensive Care Unit of Zhongshan People's Hospital from January 2015 to December 2021, involving the neonates' general information, clinical diagnosis, laboratory results, duration of ECMO treatment, complications during ECMO treatment, length of hospital stay, and outcome. Results Of the 11 neonates, 10 (91%) had successful weaning from ECMO, and 8 (73%) survived. For the 11 neonates, the mean duration of ECMO treatment was (81±50) hours (range: 26 to 185 hours), the mean duration of ventilator use was (198±105) hours (range: 57 to 392 hours), and the mean length of hospital stay was (22±15) days (range: 2 to 49 days). The oxygenation index and blood lactate level were significantly improved after 24 hours of ECMO treatment among the 11 neonates (P<0.05). Ten neonates had significantly reduced pulmonary artery pressure after 24 hours of ECMO treatment (P<0.05). One neonate had a progressive increase in the pulmonary artery pressure during EMCO treatment, succumbing to death. This neonate was diagnosed with alveolar capillary dysplasia based on the histopathological findings of the lung tissue and whole-exome sequencing results. Among the 11 children, 5 had intracranial hemorrhage, 1 had disseminated intravascular coagulation, 1 had gastric hemorrhage, 2 had pulmonary hemorrhage, 1 had renal insufficiency, and 3 had bleeding at the puncture site during ECMO treatment. Conclusions ECMO is effective for the treatment of PPHN, however, the high incidence of complications of ECMO treatment suggests that it is important to carefully assess the indications and timing of ECMO treatment and improve the management of ECMO, which can improve the weaning rate and survival rate.

Key words： Extracorporeal membrane oxygenation Persistent pulmonary hypertension Alveolar capillary dysplasia Neonate

收稿日期: 2022-02-14

通讯作者: 杨秀芳，女，主任医师。Email：yxf8787@163.com。 E-mail: yxf8787@163.com

作者简介: 陈玉兰，女，硕士，副主任医；

引用本文:

陈玉兰,杨秀芳,陈简等. 体外膜肺氧合技术在持续肺动脉高压新生儿救治中的临床应用[J]. 中国当代儿科杂志, 2022, 24(7): 786-791.

CHEN Yu-Lan,YANG Xiu-Fang,CHEN Jian et al. Application of extracorporeal membrane oxygenation in the treatment of persistent pulmonary hypertension of the newborn[J]. CJCP, 2022, 24(7): 786-791.

链接本文:

http://www.zgddek.com/CN/10.7499/j.issn.1008-8830.2202053 或 http://www.zgddek.com/CN/Y2022/V24/I7/786

	Donald DE, Harshbarger HG, Kirklin JW. Studies in extracorporeal circulation. II. A method for the recovery and use of blood from the open heart during extracorporeal circulation in man[J]. Ann Surg, 1956, 144(2): 223-227. PMID: 13355195.PMCID: PMC1465317. DOI: 10.1097/00000658-195608000-00013.
	2 Extracorporeal Life Support Organization. ELSO guidelines for cardiopulmonary extracorporeal life support[EB/OL]. (2017-08)[2022-01]. https://www.elso.org/Resources/Guidelines.aspx.
	Bartlett RH, Gazzaniga AB, Fong SW, et al. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases[J]. J Thorac Cardiovasc Surg, 1977, 73(3): 375-386. PMID: 839827.
	4 Extracorporeal Life Support Organization. Extracorporeal Life Support Organization registry report: international summary[EB/OL]. (2022-04)[2022-06]. https://www.elso.org/Registry/InternationalSummaryandReports/InternationalSummary.aspx.
	中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿肺动脉高压诊治专家共识[J]. 中华儿科杂志, 2017, 55(3): 163-168. PMID: 28273698. DOI: 10.3760/cma.j.issn.0578-1310.2017.03.002.
	中国医师协会新生儿科医师分会, 《中华儿科杂志》编辑委员会. 新生儿呼吸衰竭体外膜肺氧合支持专家共识[J]. 中华儿科杂志, 2018, 56(5): 327-331. PMID: 29783816. DOI: 10.3760/cma.j.issn.0578-1310.2018.05.003.
	Wild KT, Rintoul N, Kattan J, et al. Extracorporeal life support organization (ELSO): guidelines for neonatal respiratory failure[J]. ASAIO J, 2020, 66(5): 463-470. PMID: 32282347. DOI: 10.1097/MAT.0000000000001153.
	8 Extracorporeal Life Support Organization. Guidelines for pediatric cardiac failure[EB/OL]. (2021-05)[2022-01]. https://www.pediatriccardiaclearningcenter.org/guidelines/cardiac/ELSO%202018%20Guidelines-%20Pediatric%20Cardiac%20Failure.pdf.
	Sen P, Yang Y, Navarro C, et al. Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain[J]. Hum Mutat, 2013, 34(6): 801-811. PMID: 23505205. PMCID: PMC3663886. DOI: 10.1002/humu.22313.
	Pradhan A, Dunn A, Ustiyan V, et al. The S52F FOXF1 mutation inhibits STAT3 signaling and causes alveolar capillary dysplasia[J]. Am J Respir Crit Care Med, 2019, 200(8): 1045-1056. PMID: 31199666. PMCID: PMC6794119. DOI: 10.1164/rccm.201810-1897OC.
	Jenks CL, Raman L, Dalton HJ. Pediatric extracorporeal membrane oxygenation[J]. Crit Care Clin, 2017, 33(4): 825-841. PMID: 28887930. DOI: 10.1016/j.ccc.2017.06.005.
	12 王刚, 洪小杨, 王辉, 等. 新生儿经颈内静脉-颈总动脉置管建立体外膜氧合的操作经验[J]. 中国体外循环杂志, 2020, 18(4): 208-211. DOI: 10.13498/j.cnki.chin.j.ecc.2020.04.04.
	13 李小兵, 颜崇兵, 崔云, 等. 体外膜氧合技术在危重症新生儿救治的临床应用[J]. 中国体外循环杂志, 2021, 19(1): 8-12. DOI: 10.13498/j.cnki.chin.j.ecc.2021.01.03.
	中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿肺动脉高压诊治专家共识[J]. 中华儿科杂志, 2017, 55(3): 163-168. PMID: 28273698. DOI: 10.3760/cma.j.issn.0578-1310.2017.03.002.
	Lazar DA, Cass DL, Olutoye OO, et al. The use of ECMO for persistent pulmonary hypertension of the newborn: a decade of experience[J]. J Surg Res, 2012, 177(2): 263-267. PMID: 22901797. DOI: 10.1016/j.jss.2012.07.058.
	16 周新华, 李宁, 韩慧霞, 等. 新生儿肺泡毛细血管发育不良尸体解剖病理观察和分析[J]. 广东医学, 2010, 31(20): 2739. DOI: 10.3969/j.issn.1001-9448.2010.20.061.
	李宁, 陈红武, 周新华, 等. 呼吸衰竭死亡新生儿肺血管疾病的临床病理分析: 附38例报告[J]. 南方医科大学学报, 2017, 37(4): 528-532. PMID: 28446408.PMCID: PMC6744086. DOI: 10.3969/j.issn.1673-4254.2017.04.18.
	Melly L, Sebire NJ, Malone M, et al. Capillary apposition and density in the diagnosis of alveolar capillary dysplasia[J]. Histopathology, 2008, 53(4): 450-457. PMID: 18983610. DOI: 10.1111/j.1365-2559.2008.03134.x.
	李宁, 周新华, 陈红武, 等. 肺泡毛细血管发育不良一例报告并文献复习[J]. 中华儿科杂志, 2010, 48(9): 674-679. PMID: 21092526. DOI: 10.3760/cma.j.issn.0578-1310.2010.09.009.
	Fleming GM, Sahay R, Zappitelli M, et al. The incidence of acute kidney injury and its effect on neonatal and pediatric extracorporeal membrane oxygenation outcomes: a multicenter report from the kidney intervention during extracorporeal membrane oxygenation study group[J]. Pediatr Crit Care Med, 2016, 17(12): 1157-1169. PMID: 27755398.PMCID: PMC5138084. DOI: 10.1097/PCC.0000000000000970.
	21 司念, 李可, 魏晴. 体外膜肺氧合支持下的输血策略[J]. 临床输血与检验, 2021, 23(4): 412-415. DOI: 10.3969/j.issn.1671-2587.2021.04.002.
	Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation[J]. Semin ThrombHemost, 2018, 44(1): 20-29. PMID: 28898902. DOI: 10.1055/s-0037-1606179.